In vivo mutation analysis and treatment of Gq mutated uveal melanoma

被引：0
|
作者：
Posch, C. [1 ,2 ]
Somoza, A. [3 ]
Crosby, M. B. [4 ]
Moslehi, H. [1 ]
Green, G. [1 ]
Ortiz-Urda, S. [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Rudolfstiftung Hosp, Vienna, Austria
[3] IMDEA Nanosci, Madrid, Spain
[4] N Cty Eye Surg Associates, San Diego, CA USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2012年 / 132卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
759
引用
收藏
页码：S130 / S130
页数：1
相关论文
共 50 条
  • [1] Direct pharmacological targeting of Gq/11 in uveal melanoma
    Onken, Michael D.
    Makepeace, Carol M.
    Wang, Shiqi
    Kaltenbronn, Kevin M.
    Kanai, S. Michinobu
    Broekelmann, Tom J.
    Cooper, John A.
    Blumer, Kendall J.
    CANCER RESEARCH, 2017, 77
  • [2] Treatment of QNAQ mutated, advanced Uveal Melanoma with the MEK Inhibitor Trametinib
    Sakar, H.
    Scholler, A.
    Gaiser, M. R.
    Utikal, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 49 - 49
  • [3] Pharmacologic targeting of Gq reveals new pathways in uveal melanoma
    Onken, Michael D.
    Makepeace, Carol M.
    Wang, Shiqi
    Kaltenbronn, Kevin M.
    Kanai, Stanley M.
    Broekelmann, Tom J.
    Cooper, John A.
    Blumer, Kendall J.
    CANCER RESEARCH, 2018, 78 (13)
  • [4] Mutation analysis of the PTEN gene in uveal melanoma cell lines
    Naus, NC
    Zuidervaart, W
    Rayman, N
    Slater, R
    van Drunen, E
    Ksander, B
    Luyten, GPM
    Klein, A
    INTERNATIONAL JOURNAL OF CANCER, 2000, 87 (01) : 151 - 153
  • [5] Mutant Gq/11 Promote Uveal Melanoma Tumorigenesis by Activating YAP
    Yu, Fa-Xing
    Luo, Jing
    Mo, Jung-Soon
    Liu, Guangbo
    Kim, Young Chul
    Meng, Zhipeng
    Zhao, Ling
    Peyman, Gholam
    Ouyang, Hong
    Jiang, Wei
    Zhao, Jiagang
    Chen, Xu
    Zhang, Liangfang
    Wang, Cun-Yu
    Bastian, Boris C.
    Zhang, Kang
    Guan, Kun-Liang
    CANCER CELL, 2014, 25 (06) : 822 - 830
  • [6] Pharmacologic targeting of Gq reveals new pathways in uveal melanoma.
    Onken, Michael D.
    Makepeace, Carol M.
    Kaltenbronn, Kevin M.
    Kanai, Stanley M.
    Todd, Tyson D.
    Wang, Shiqi
    Broekelmann, Thomas J.
    Rao, Prabakar Kumar
    Cooper, John A.
    Blumer, Kendall J.
    CANCER RESEARCH, 2020, 80 (19) : 27 - 28
  • [7] Analysis of melanoma cell type in uveal melanoma following treatment failure
    Char, DH
    Miller, T
    Crawford, JB
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2004, 138 (04) : 543 - 546
  • [8] GNQ-209P Mutation in Metastatic Uveal Melanoma and Treatment Outcome
    Karim, Nagla Abdel
    Eldessouki, Ihab
    Taftaf, Ahmad
    Ayham, Deeb
    Gaber, Ola
    Makramalla, Abouelmagd
    Correa, Zelia M.
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2018, 2018
  • [9] Chromosomal aberration predicts uveal melanoma mutation
    Verdijk, R. M.
    Drabarek, W.
    Yavuzyigitoglu, S.
    van Poppelen, N.
    Smit, K.
    Dubbink, H. J.
    Paridaens, D.
    Kilic, E.
    de Klein, A.
    VIRCHOWS ARCHIV, 2017, 471 : S47 - S47
  • [10] Lack of BRAF mutation in primary uveal melanoma
    Cohen, Y
    Goldenberg-Cohen, N
    Parrella, P
    Chowers, I
    Merbs, SL
    Pe'er, J
    Sidransky, D
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (07) : 2876 - 2878
12345